Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Serotype replacement after pneumococcal vaccination.

Mulholland K, Satzke C.

Lancet. 2012 Apr 14;379(9824):1387; author reply 1388-9. doi: 10.1016/S0140-6736(12)60588-1. No abstract available.

PMID:
22500869
2.

Serotype replacement after pneumococcal vaccination.

DiNubile MJ.

Lancet. 2012 Apr 14;379(9824):1388; author reply 1388-9. doi: 10.1016/S0140-6736(12)60590-X. No abstract available.

PMID:
22500870
3.

Serotype replacement after pneumococcal vaccination.

Hausdorff WP, Van Dyke MK, Van Effelterre T.

Lancet. 2012 Apr 14;379(9824):1387-8; author reply 1388-9. doi: 10.1016/S0140-6736(12)60589-3. No abstract available.

PMID:
22500868
4.

Serotype replacement in invasive pneumococcal disease: where do we go from here?

Hanage WP.

J Infect Dis. 2007 Nov 1;196(9):1282-4. Epub 2007 Oct 4. No abstract available.

PMID:
17922390
5.

[Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].

Kenzel S, Hufnagel M, Berner R, Henneke P.

Dtsch Med Wochenschr. 2010 Jun;135(23):1198-200. doi: 10.1055/s-0030-1247868. Epub 2010 May 17. German. No abstract available.

PMID:
20480453
6.

Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults.

Grabenstein JD.

Clin Infect Dis. 2012 Jul;55(2):255-8. doi: 10.1093/cid/cis354. Epub 2012 Apr 11. No abstract available.

PMID:
22495543
7.

Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine.

Hoberman A, Paradise JL, Shaikh N, Greenberg DP, Kearney DH, Colborn DK, Rockette HE, Kurs-Lasky M, McEllistrem MC, Zoffel LM, Balentine TL, Barbadora KA, Wald ER.

Clin Pediatr (Phila). 2011 Feb;50(2):114-20. doi: 10.1177/0009922810384259. Epub 2010 Nov 22.

PMID:
21098526
8.

Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.

Beall B.

Expert Rev Vaccines. 2007 Jun;6(3):297-300. No abstract available.

PMID:
17542743
9.

Why it is still important that countries know the burden of pneumococcal disease.

Prato R, Tafuri S, Fortunato F, Martinelli D.

Hum Vaccin. 2010 Nov;6(11):918-21. Epub 2010 Nov 1. Review. No abstract available.

PMID:
21045538
10.

Challenges to pneumococcal vaccine in India.

Kanungo R.

Indian J Med Microbiol. 2013 Jan-Mar;31(1):1-2. doi: 10.4103/0255-0857.108701. No abstract available.

11.

Vaccination against invasive pneumococcal disease in Saudi Arabia: where do we stand?

Frayha HH, Al Mazrou YY.

Ann Saudi Med. 2005 Mar-Apr;25(2):90-3. No abstract available.

PMID:
15977683
12.

[Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].

Moraga-Llop FA.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):1-4. doi: 10.1016/j.eimc.2008.09.002. Epub 2009 Jan 3. Spanish. No abstract available.

PMID:
19217995
13.

The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes.

Tyrrell GJ.

J Infect Dis. 2011 May 15;203(10):1345-7. doi: 10.1093/infdis/jir056. Epub 2011 Mar 11. No abstract available.

14.

Serotype 19A Streptococcus pneumoniae among Indian isolates is a cause for concern.

Shariff M, Zahoor S, Deb M.

Indian J Med Microbiol. 2012 Jan-Mar;30(1):112. doi: 10.4103/0255-0857.93085. No abstract available.

15.

Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement.

Nurhonen M, Auranen K.

PLoS Comput Biol. 2014 Feb 13;10(2):e1003477. doi: 10.1371/journal.pcbi.1003477. eCollection 2014 Feb.

16.

Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.

dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB.

Vaccine. 2013 Dec 9;31(51):6150-4. doi: 10.1016/j.vaccine.2013.05.042. Epub 2013 Jun 6.

17.

The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.

Black S.

Pediatr Infect Dis J. 2010 Apr;29(4):301-3. doi: 10.1097/INF.0b013e3181c391fb. Review. No abstract available.

PMID:
19935444
18.

Baseline epidemiology and genetic structure of Streptococcus pneumoniae serotype 6D in southern Israel prior to introduction of pneumococcal conjugate vaccines.

Porat N, Benisty R, Trefler R, Ozalvo D, Givon-Lavi N, Dagan R.

J Clin Microbiol. 2013 May;51(5):1580-2. doi: 10.1128/JCM.03320-12. Epub 2013 Feb 27.

19.

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Lancet Infect Dis. 2011 Oct;11(10):760-8. doi: 10.1016/S1473-3099(11)70090-1. Epub 2011 May 27.

PMID:
21621466
20.

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.

Rückinger S, von Kries R, Reinert RR, van der Linden M, Siedler A.

Vaccine. 2008 Jul 29;26(32):3984-6. doi: 10.1016/j.vaccine.2008.04.031. Epub 2008 May 5.

PMID:
18495301

Supplemental Content

Support Center